These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 19350631

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A distinct subpopulation within CD133 positive brain tumor cells shares characteristics with endothelial progenitor cells.
    Choi SA, Wang KC, Phi JH, Lee JY, Park CK, Park SH, Kim SK.
    Cancer Lett; 2012 Nov 28; 324(2):221-30. PubMed ID: 22652175
    [Abstract] [Full Text] [Related]

  • 23. CD133 as a marker for cancer stem cells: progresses and concerns.
    Wu Y, Wu PY.
    Stem Cells Dev; 2009 Oct 28; 18(8):1127-34. PubMed ID: 19409053
    [Abstract] [Full Text] [Related]

  • 24. Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3.
    Guo R, Wu Q, Liu F, Wang Y.
    Oncol Rep; 2011 Jan 28; 25(1):141-6. PubMed ID: 21109969
    [Abstract] [Full Text] [Related]

  • 25. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
    Rutella S, Bonanno G, Procoli A, Mariotti A, Corallo M, Prisco MG, Eramo A, Napoletano C, Gallo D, Perillo A, Nuti M, Pierelli L, Testa U, Scambia G, Ferrandina G.
    Clin Cancer Res; 2009 Jul 01; 15(13):4299-311. PubMed ID: 19509143
    [Abstract] [Full Text] [Related]

  • 26. Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes.
    Baxter PA, Lin Q, Mao H, Kogiso M, Zhao X, Liu Z, Huang Y, Voicu H, Gurusiddappa S, Su JM, Adesina AM, Perlaky L, Dauser RC, Leung HC, Muraszko KM, Heth JA, Fan X, Lau CC, Man TK, Chintagumpala M, Li XN.
    Acta Neuropathol Commun; 2014 Dec 20; 2():160. PubMed ID: 25526772
    [Abstract] [Full Text] [Related]

  • 27. Targeting cancer stem cells through L1CAM suppresses glioma growth.
    Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE, Hjelmeland AB, Rich JN.
    Cancer Res; 2008 Aug 01; 68(15):6043-8. PubMed ID: 18676824
    [Abstract] [Full Text] [Related]

  • 28. [Sorting of CD133(+) subset cells in human gastric cancer and the identification of their tumor initiating cell-like properties].
    Lu RQ, Wu JG, Zhou GC, Jiang HG, Yu JW, Jiang BJ.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb 01; 15(2):174-9. PubMed ID: 22368028
    [Abstract] [Full Text] [Related]

  • 29. Expression of multidrug resistance genes in normal and cancer stem cells.
    Shervington A, Lu C.
    Cancer Invest; 2008 Jun 01; 26(5):535-42. PubMed ID: 18568776
    [Abstract] [Full Text] [Related]

  • 30. [Isolation and culture of tumor stem cells from human brain glioma tissues].
    Huang Q, Dong J, Zhu YD, Zhang QB, Ji XY, Wang AD, Lan Q.
    Zhonghua Zhong Liu Za Zhi; 2006 May 01; 28(5):331-3. PubMed ID: 17044993
    [Abstract] [Full Text] [Related]

  • 31. PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells.
    Cheng RB, Ma RJ, Wang ZK, Yang SJ, Lin XZ, Rong H, Ma Y.
    Mol Cell Biochem; 2011 Mar 01; 349(1-2):149-57. PubMed ID: 21110069
    [Abstract] [Full Text] [Related]

  • 32. The cyclin-like protein Spy1 regulates growth and division characteristics of the CD133+ population in human glioma.
    Lubanska D, Market-Velker BA, deCarvalho AC, Mikkelsen T, Fidalgo da Silva E, Porter LA.
    Cancer Cell; 2014 Jan 13; 25(1):64-76. PubMed ID: 24434210
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Experimental investigation of CD133 as a putative marker of tumor-initiating cell in laryngeal carcinoma].
    Wei XD, Zhou L, Cheng L, Tian J.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Dec 13; 41(12):940-4. PubMed ID: 17345710
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Proteomic profiling of tumor-initiating cells in HT-29 human colorectal cancer cells.
    Lee HN, Park SH, Lee EK, Bernardo R, Kim CW.
    Biochem Biophys Res Commun; 2012 Oct 12; 427(1):171-7. PubMed ID: 22995320
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis.
    Pallini R, Ricci-Vitiani L, Montano N, Mollinari C, Biffoni M, Cenci T, Pierconti F, Martini M, De Maria R, Larocca LM.
    Cancer; 2011 Jan 01; 117(1):162-74. PubMed ID: 20806346
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.